Rocket 4D Receives Positive Customer Commentary
Genevac has reported very positive feedback from early adopters of their Rocket 4D — a fully automated system for automatic drying or concentration of very large volumes up to 100 L.
Launched worldwide during the summer of 2013, Genevac has received considerable interest from laboratories drawn by the ease of use, automated productivity and performance of the Rocket 4D.
A chemistry scale-up laboratory at a major pharma company, running kilo-scale preparative SFC, was drawn by the unattended automation offered by the Rocket 4D. Traditionally removing large volumes of methanol from their sample fractions using a number of rotary evaporators required a dedicated operator to top-up dry ice in cold traps, feed the systems with more product and watch the systems continually. The operator commented: "With the Rocket 4D you simply load your sample, select a method, press start, and walk away — the system will do the rest." He added that he “got his life back” when the 4D arrived and now is able to spend his time much more productively.
A natural products research group, at a US Ivy League university, was faced with concentrating large volumes of aqueous extracts from vegetable tubers. Typical workflow for their chosen system for this new project would be for many scientists to have occasional access to the system. The university selected the Rocket 4D as it was easiest to operate, had technology to prevent sample bumping and did not require users to handle and clean large heavy glass evaporation vessels.
Compact in size the Rocket 4D allows you to dry or concentrate your samples with complete confidence as it uses proprietary vacuum technology to suppress solvent bumping and foaming — problems associated with sample loss when using large-scale rotary evaporators.
The Rocket 4D comes as standard with a single, 5-L 316 stainless steel vessel for drying or concentrating product. This has detachable handles and is easily lifted into and out of the evaporator. Access to the dried or concentrated product in the vessel is very easy. Dried products can be scooped out, or where enhanced user protection is needed, re-dissolved while the vessel is still in the system.
Liquid products can be easily drained via a drain port in the side of the rotor, using a dedicated pouring stand. Users wishing to dry volumes larger than five litres require the ‘Autofeed’ option, which enables the Rocket 4D to draw in product from the user’s own external supply.
The Rocket 4D controls product feed, drying and the discharge of condensed waste solvent without any external intervention. The autofeed system has an integrated rinse circuit which enables dried products to be automatically re-dissolved in a small volume of solvent at the end of the process. Alternatively, the same circuit can be used under manual control for solvent exchange, by selecting a different solvent for re-dissolve. Cleaning the Rocket 4D between cycles is also very straightforward. The PTFE feed tubing is easily detached for cleaning or replacement and the vessel can be readily cleaned, wiped, inspected and even put in a dishwasher. The Rocket 4D also includes powerful cold traps that maximise solvent recovery protecting the environment and improving drying of samples.
Related News
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance